You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Details for Patent: 8,956,651

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,956,651 protect, and when does it expire?

Patent 8,956,651 protects RELISTOR and is included in one NDA.

This patent has fifty-four patent family members in thirty-one countries.

Summary for Patent: 8,956,651

Title:	Oral formulations and lipophilic salts of methylnal trexone
Abstract:	The present invention provides compositions comprising methylnaltrexone or a salt thereof, and compositions and formulations thereof, for oral administration.
Inventor(s):	Shah; Syed M. (Delray Beach, FL), Diorio; Christopher Richard (Campbell Hall, NY), Ehrnsperger; Eric C. (New City, NY), Meng; Xu (San Diego, CA), Al Shareffi; Kadum A. (North Potomac, MD), Cohen; Jonathan Marc (Monroe, NY)
Assignee:	Wyeth, LLC (Madison, NJ)
Application Number:	13/966,779
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,956,651
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Dosage form; Device;

Drugs Protected by US Patent 8,956,651

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Salix	RELISTOR	methylnaltrexone bromide	TABLET;ORAL	208271-001	Jul 19, 2016		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,956,651

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	080491	⤷ Try a Trial
Australia	2011224275	⤷ Try a Trial
Brazil	112012022873	⤷ Try a Trial
Canada	2789798	⤷ Try a Trial
Chile	2012002192	⤷ Try a Trial
China	102918039	⤷ Try a Trial
China	107308125	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.